September 27 – October 1, 2019 Barcelona, Spain Poster presentation: Peripheral cytotoxic T cell correlates with tumor mutational burden and is predictive for progression free survival in advanced breast cancer
September 19-21, 2019 Xiamen, China Details: Exhibition booth: T07 at B7Hall Satellite symposium: September 20, 2019
August 20 – 22, 2019 Washington DC Details: Exhibition booth # 205 Presentation: Reshaping Oncology Drug Development Landscape with ctDNA + ctRNA Liquid Biopsy Solutions | August 20, 2019
May 31-June 4, 2019 Chicago, IL Details: Exhibition booth #19135 Satellite symposium: New Era of Biomarker-driven Clinical Trials and Regulatory Approvals in US and China |June 1, 2019 Poster Presentations: Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and metastatic castration resistant...
March 31 – April 3, 2019 Atlanta, Georgia Details: Exhibition booth #4322 Satellite symposium: Biomarker-driven Precision Oncology | March 31, 2019 Poster Presentations: Prognostic and predictive utility of copy number variations (CNVs) in circulating tumor DNA (ctDNA) from metastatic castration-resistant prostate cancer (mCRPC) patients!/6812/presentation/4859 Combined immunohistochemistry and NGS-based patient profiling for predicting anti-PD-1/PD-L1 therapy...
October 19-23, 2018 Munich, Germany Poster presentation: Circulating tumor DNA and RNA as an exploratory biomarker to evaluate GT0918 in a phase I/II clinical trial in mCRPC patients